Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1022

Streptococcus salivarius DB-B5

Intended Use: Intended for use as an ingredient in conventional foods at a use level up to 109 CFU of S. salivarius DB-B5/serving.
Basis: Scientific procedures
Notifier: Dose Biosystems Inc.
Notifier Address: 661 University Ave, Suite 1300
Toronto, Ontario
Canada
M5G0B7
GRAS Notice (releasable information): GRN 1022 with amendments (in PDF) (16.4 MB)
Date of closure: Aug 22, 2022
FDA's Letter: FDA has no questions (in PDF) (177 kB)
-
-